ACADIA Pharmaceuticals (ACAD) moves higher in after-hours trade following the announcement that...

|About: ACADIA Pharmaceuticals Inc. (ACAD)|By:, SA News Editor

ACADIA Pharmaceuticals (ACAD) moves higher in after-hours trade following the announcement that it will host a conference call and webcast at 8:00 a.m. EST on Tuesday, November 27, to present the top-line results from its Phase III trial of pimavanserin, a treatment for patients with Parkinson's disease psychosis. Shares +6.5% AH.